2 weeks Ago
Moderna, Inc. ( NASDAQ: MRNA ) UBS Global Healthcare Conference November 13, 2024 6:30 PM ET Company Participants Jamey Mock - Chief Financial Officer Conference Call Participants Eliana Merle - UBS Eliana Merle Good afternoon, everyone. Thank you for joining us at the UBS Healthcare Conference.
I'm Eliana Merle. I'm one of the biotech analysts here at UBS. Very happy to have Moderna here with us today for fireside chat.
Joining us from Moderna is Jamey Mock, Chief Financial Officer. Jamey, thank you so much for joining us. Question-and-Answer Session Q - Eliana Merle Maybe to kick it off, you had a strong third quarter, but we've seen the recent stock move, maybe what are some of the implications of the recent election and potential political headwinds, or potential noise that you're at least hearing from a headline perspective? Jamey Mock Well, first off, thanks for having us.
It's great to be here, and thanks to UBS as well. Yes. So we'll get into the quarter, which we thought was a good one.
But yes, there seems to be some amount of political overhang. When we look at it, I think it's more noise right now than actually a long-term effect. I think if you listen to what's been said, nobody is saying that they're going to take away vaccines.
I think a lot of people want the actual data and the science to be shared, and we stand behind our science, and we stand behind our data. So we've always led with Science First mentality. We believe in our products.
We have to take all the right precautions around that. So I'm hopeful when the truth comes out around that, that everything - it will be more noise than actual change. So - and in the past, we've worked with the Trump administration in the.
